SLC/CCL21-mediated anti-tumor responses require IFNγ, MIG/CXCL9 and IP-10/CXCL10

BACKGROUND: SLC/CCL21, normally expressed in high endothelial venules and in T cell zones of spleen and lymph nodes, strongly attracts T cells and dendritic cells (DC). We have previously shown that SLC/CCL21-mediated anti-tumor responses are accompanied by significant induction of IFNγ and the CXC...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Sherven, Yang, Seok-Chul, Hillinger, Sven, Zhu, Li X, Huang, Min, Batra, Raj K, Lin, Jeff F, Burdick, Marie D, Strieter, Robert M, Dubinett, Steven M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC155639/
https://www.ncbi.nlm.nih.gov/pubmed/12740040
http://dx.doi.org/10.1186/1476-4598-2-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC155639/
https://www.ncbi.nlm.nih.gov/pubmed/12740040
http://dx.doi.org/10.1186/1476-4598-2-22

Ejemplares similares